share_log

Appili Therapeutics Inc. Expected to Post FY2023 Earnings of ($0.08) Per Share (TSE:APL)

Defense World ·  Feb 25, 2023 16:43

Appili Therapeutics Inc. (TSE:APL – Get Rating) – Analysts at Zacks Small Cap increased their FY2023 earnings per share (EPS) estimates for shares of Appili Therapeutics in a research note issued to investors on Tuesday, February 21st. Zacks Small Cap analyst D. Bautz now expects that the company will earn ($0.08) per share for the year, up from their previous forecast of ($0.09).

Get Appili Therapeutics alerts:

Appili Therapeutics (TSE:APL – Get Rating) last posted its quarterly earnings results on Tuesday, February 14th. The company reported C($0.02) earnings per share for the quarter, hitting the consensus estimate of C($0.02). The business had revenue of C$0.01 million during the quarter.

Appili Therapeutics Price Performance

Read More

  • Carvana Skidding On Revenue Decrease, Heavy Debt Burden
  • What Are Consumer Staples Stocks?
  • Is Rocky Brands Dividend A Good Fit For Your Portfolio?
  • Beyond Meat Stock Is Not Beyond Hope
  • Analysts Holding As Pfizer Waits On Two Phase 3 Studies

Receive News & Ratings for Appili Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Appili Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment